European Edition
HEPATOLOGY
Suppl. 1 February 2020 emjreviews.com
+ AASLD 2019
New Data on AramcholTM
for the Treatment of
Non-alcoholic Steatohepatitis:
Exploring Potential for
Greater Efficacy and the
Effect on Glucose Metabolism
New Data on AramcholTM for the Treatment of
Non-alcoholic Steatohepatitis: Exploring Potential
for Greater Efficacy and the Effect on
Glucose Metabolism
These poster presentations took place from 8th to 12th November 2019,
as part of the ‘Liver Meeting®’ organised by the American Association
for the Study of Liver Diseases (AASLD), held in Boston,
Massachusetts, USA
Presenters: Graham Trevitt,1 José M. Mato2
1. XenoGesis, BioCity, Nottingham, UK
2. CIC bioGUNE, Derio, Bizkaia, Spain
D European Edition HEPATOLOGY Suppl. 1 Februar New Data on AramcholTM for the Treatment of N Increased Exposure of Aramchol by Using a Split D A Area under the curve (0-24) 150,000 Aramch The researchers added 13C-labelled glucose to Ara